India to Ecuador: Rivaroxaban Export Trade Route

The India to Ecuador Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $3.2M USD. The route is dominated by CARITAS HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $108.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with rivaroxaban's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 29.0%, placing it at rank #13 among India's top rivaroxaban export destinations globally.

On the import side, key buyers of Indian rivaroxaban in Ecuador include TO THE PURCHASE MANAGER, F.D.E.C.A, TO THE PURCHASE MANAGER and 4 others. TO THE PURCHASE MANAGER is the single largest importer with 4 shipments valued at $2.6M USD.

India's rivaroxaban exports to Ecuador are driven primarily by a handful of large-scale manufacturers. CARITAS HEALTHCARE PRIVATE LIMITED with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Ecuador benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CARITAS HEALTHCARE PRIVATE LIMITED, CARITAS HEALTHCARE PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED — together account for 99% of total trade value on this route. The average shipment value of $108.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as finished pharamceutical product-rivaroxaban tablet 20mg b.no.emv240158b,emv240157b,emv240157a and finished pharmaceutical product - rivaroxaban tablets 20mg batch no. emv240857 emv240856b, suggesting that buyers in Ecuador tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE PURCHASE MANAGER is the largest importer with 4 shipments worth $2.6M USD — representing 81% of all rivaroxaban imports from India on this route. A total of 7 buyers are active on this corridor.